Single Peptide11 mg
Semax (11 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE11 mg
RECONSTITUTION3.0 mL bacteriostatic water
CONCENTRATION3.67 mg/mL
ROUTESubcutaneous injection
FREQUENCYOnce daily or every other day
CYCLE LENGTH2–4 weeks (intensive) or 8–12 weeks (gradual)
DOSE RANGE0.5–3.0 mg/day
STORAGE−20 °C lyophilized / 2–8 °C reconstituted
Overview
Semax is a neurotropic heptapeptide that elevates BDNF and supports cognitive performance. Morning dosing preferred for alertness protocols. Intensive short courses (2–4 weeks) are common.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.5 mg (500 mcg) | 14 units | 0.14 mL |
| Weeks 3–4 | 1.0 mg (1,000 mcg) | 27 units | 0.27 mL |
| Advanced | 3.0 mg (3,000 mcg) | 82 units | 0.82 mL |
Reconstitution Instructions
1.
Draw 3.0 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl/roll until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Peptide Vials (Semax, 11 mg): 1–2 vials
- ✓Insulin Syringes (U-100): 28 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 56 swabs
Dosing Protocol
Schedule
Once daily, morning preferred for cognitive/alertness protocols.
Cycle Structure
Intensive: 2–4 weeks. Gradual: 8–12 weeks.
Timing
Morning for cognitive enhancement.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Discard if solution becomes cloudy or contains visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.